A rapid point-of-care test designed for health provider settings to detect Influenza A and B antigens. The test is 510(k) cleared and provides rapid results for influenza identification.
Manufactured by
United States
Wondfo USA is a branch of Wondfo Biotech Co., Ltd. located in the United States. Wondfo USA distributes rapid drug testing kits as well as other POCT products, which are manufactured by its parent company. Headquartered in Guangzhou, China, Wondfo is a globally recognized fast-growing POCT manufacturer specialized in R&D, manufacture, and sales of rapid diagnostic tests and related medical devices for in vitro diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Boston Easy Biotech Inc.
United States · 2 relevant products
Anbio Biotechnology Limited
Germany · 1 relevant product
ProGnosis Biotech S.A.
Greece · 3 relevant products
Bio-Novum Sp.z o.o.
Poland · 1 relevant product
Ningbo Masschip Intelligent Technology Co., Ltd.
China · 1 relevant product
Zhejiang Orient Gene Biotech Co.,Ltd.
China · 1 relevant product
K.Bio Sciences Co., Ltd.
Thailand · 1 relevant product
Shanghai Chemtron Biotech Co.,Ltd.
China · 1 relevant product
GenSure Biotech Inc.
China · 2 relevant products
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD
China · 1 relevant product
64 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 112 closest product alternatives
Boston Easy Biotech Inc. · United States
FDA-cleared rapid diagnostic test for simultaneous detection of Influenza A and B antigens. Provides fast, reliable results in clinical and point-of-care settings. Designed for ease of use and quick turnaround in respiratory infection screening.
Boston Easy Biotech Inc. · United States
FDA-cleared rapid antigen test for simultaneous detection of Influenza A and B. Designed for clinical and point-of-care settings, this test delivers fast, reliable results to support timely diagnosis and patient management. Suitable for respiratory screening in healthcare facilities and retail pharmacy channels.
Anbio Biotechnology Limited · Germany
Rapid immunochromatographic assay for simultaneous detection of influenza A and B viral antigens. Provides point-of-care results for acute respiratory illness diagnosis.
ProGnosis Biotech S.A. · Greece
Rapid lateral flow test kit for simultaneous Influenza A and B detection. Validated diagnostic tool certified to ISO 13485:2016 medical device standards.
Bio-Novum Sp.z o.o. · Poland
Rapid immunochromatographic test for simultaneous detection of Influenza A and B antigens in respiratory samples. Delivers results within 10-15 minutes, enabling quick clinical decision-making in point-of-care and laboratory settings. Intended for use during suspected influenza infection to guide treatment and infection control protocols.
Ningbo Masschip Intelligent Technology Co., Ltd. · China
Rapid immunoassay test for influenza A and B detection. Provides quick results for patient stratification and treatment decisions.
Zhejiang Orient Gene Biotech Co.,Ltd. · China
Point-of-care diagnostic test for simultaneous detection of influenza A and B viruses. Results available within 10-15 minutes, enabling rapid clinical decision-making.
K.Bio Sciences Co., Ltd. · Thailand
Rapid lateral flow immunochromatographic test for qualitative detection of Influenza A and B antigens in respiratory specimens. Delivers results within minutes using a single-use test device, enabling quick clinical decision-making in point-of-care and laboratory settings.
Shanghai Chemtron Biotech Co.,Ltd. · China
Point-of-care test for the simultaneous detection of influenza A and B viruses in respiratory samples. Enables rapid differentiation between influenza strains for clinical management.
GenSure Biotech Inc. · China
Rapid antigen detection test kit for simultaneous identification of Influenza A and B viruses from respiratory specimens. Delivers results within minutes using immunochromatographic technology, enabling point-of-care diagnosis in clinical and home settings. NMPA-approved for accurate respiratory pathogen screening.
SHENZHEN MAIDE BIOTECHNOLOGY CO.,LTD · China
Rapid diagnostic test for simultaneous detection of influenza A and B viruses using nasopharyngeal or throat swab specimens. Provides reliable results for clinical decision-making in respiratory illness assessment.
Atlas Link, Inc. · United States
A rapid diagnostic test for the detection of influenza A and B viruses. The test is included in Atlas Link's respiratory and COVID-19 diagnostic portfolio with FDA registration, CE marking, and ISO 13485 certification.
100 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products